Actavis reaches settlement with indirect purchasers in Intuniv pay-for-delay case
MLex Summary: Actavis has reached a $1.1 million settlement with indirect purchaser plaintiffs in a case accusing it of engaging in an illegal pay-for-delay agreement regarding the ADHD drug Intuniv. The...To view the full article, register now.
Already a subscriber? Click here to view full article